A new drug developed as an alternative to popular drug warfarin, also used as rat poison, has been found to significantly reduce stroke risk.
Generally, patients at risk of stroke are given warfarin to prevent blood clotting, but the treatment is risky and requires regular monitoring.
Stroke
Stroke can cause permanent disability and it is important to recognize its early warning signs to stop its progress. Early warning signs of stroke include sudden weakness of facial muscles.
Advertisement
In the new study, the doctors found that the new drug, dabigatran (Pradaxa), was 34 per cent more effective at reducing the risk of stroke and blood clots in at-risk patients than well-controlled warfarin.
It also reduced death rates by 15 per cent.
In the three-year long study, the researchers recruited patients with an average age of 71, all of whom suffered from atrial fibrillation, a heart rhythm disorder that greatly increases the risk of stroke.
![Stroke - Top Ten Facts]( "Stroke - Top Ten Facts")
Stroke is the third most common cause of death and the most prominent cause of physical deformity in the world
The British Heart Foundation said that the results for an alternative to warfarin were promising, but the drug would not be available to patients until next year at the earliest.
"Warfarin is a highly effective treatment when indicated for stroke prevention, but it is underused, often because of safety concerns or the need for regular blood tests to monitor its effects," Times Online quoted Keith Muir, a medical advisor for the Stroke Association, as saying.
The trial indicates that dabigatran may offer a useful alternative to warfarin for stroke prevention in some circumstances.
"However, the trial only involved people who could equally well have taken warfarin, and anyone currently taking warfarin should continue it unless advised by their doctor," he added.
The study has been published in the New England Journal of Medicine.
Source: ANI
LIN
In the three-year long study, the researchers recruited patients with an average age of 71, all of whom suffered from atrial fibrillation, a heart rhythm disorder that greatly increases the risk of stroke.
Stroke - Top Ten Facts
Stroke is the third most common cause of death and the most prominent cause of physical deformity in the world
Advertisement
The British Heart Foundation said that the results for an alternative to warfarin were promising, but the drug would not be available to patients until next year at the earliest.
"Warfarin is a highly effective treatment when indicated for stroke prevention, but it is underused, often because of safety concerns or the need for regular blood tests to monitor its effects," Times Online quoted Keith Muir, a medical advisor for the Stroke Association, as saying.
The trial indicates that dabigatran may offer a useful alternative to warfarin for stroke prevention in some circumstances.
"However, the trial only involved people who could equally well have taken warfarin, and anyone currently taking warfarin should continue it unless advised by their doctor," he added.
The study has been published in the New England Journal of Medicine.
Source: ANI
LIN
Advertisement
 Blood Clot Drug Touted to Save Lives After SurgeryCharity Lifeblood has called on doctors to use blood-thinning drug Pradaxa (dabigatran etexilate) on a regular basis so as to avoid unnecessary deaths from fatal blood clots. | Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
Women using hormonal contraception, along with their healthcare providers, should explore alternative pain relief options instead of NSAIDs.
